Anti-VP1 and Anti-VP2 Antibodies Detected by Immunofluorescence Assays in Patients with Acute Human Parvovirus B19 Infection

Memorias do Instituto Oswaldo Cruz

Volumn 96, Issue 4, 2001, Pages 507-513

  Pereira, Renata F A ^a   De Paula, Walquiria N S ^a   Cubel, Rita De Cássia N ^a   Nascimento, Jussara P ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Instituto de Technologia em Imunobiologicos   (Brazil)

Author keywords

Human parvovirus B19; IgG and IgM antibodies; IgG avidity; Immunofluorescence; VP1 and VP2 structural proteins

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ARTICLE; BLOOD; CHILD; ERYTHEMA INFECTIOSUM; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; PARVOVIRUS; VIRUS CAPSID; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CAPSID; CHILD; ERYTHEMA INFECTIOSUM; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 0035349033     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762001000400011     Document Type: Article

References (35)

1. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, Mortimer PP 1986. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 24: 522-526.
2. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, Pattinson JR, Tyrrell DAJ 1985. Experimental parvoviral infection in human. J Infect Dis 152: 257-265.
3. Bansal GP, Hatfield JA, Dunn FE, Kramer AA, Brady F, Riggin CH, Collet MS, Yoshimoto K, Kajigaya S, Young NS 1993. Candidate recombinant vaccine for human B19 parvovirus. J Infect Dis 167: 1034-1044.
4. Brown CS, Sallimans MMM, Noteborn MHM, Weiland HT 1990a. Antigenic B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system. Virus Res 15: 197-212.
5. Brown CS, van Bussel MJAWM, Wassenaar ALM, van Elsaker-Niele AMW, Weilland HT, Salimans MMM 1990b. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen. J Virol Meths 29: 53-62.
6. Brown CS, Van Lent JWM, Vlak JM, Spaan WJM 1991. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J Virol 65: 2702-2706.
7. Bruu AL, Nordbo AS 1995. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 33: 1363-1365.
8. Cohen BJ, Bates CM 1995. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM. J Virol Meths 55: 11-25
9. Cohen BJ, Mortimer PP, Pereira MS 1983. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg Camb 91: 113-130.
10. Cotmore SF, Tattersall P 1984. Characterization and molecular cloning of a human parvovirus genome. Science 226: 1161-1165.
11. Cubel RCN, Al feres ACR, Cohen BJ, Nascimento JP 1994. Application to immunoglobulin M capture hemadherence assays of hemagglutination of monkey erythrocytes by native and recombinant human parvovirus B19 antigens. J Clin Microbiol 32: 1997-1999.
12. Cubel RCN, Siqueira MM, Santos EO, Pires MF, Cruz CMF, Nascimento JP 1997. Human parvovirus B19 infection among exanthematic diseases notified as measles. Rev Soc Bras Med Trop 30: 15-20.
13. Cubel RCN, Valadão MC, Pereira WV, Magalhães MC, Nascimento JP 1992. Aplastic crisis due to human parvovirus B19 infection in hereditary hemolytic anaemia. Rev Inst Med Trop São Paulo 35: 479-482.
14. Fridell E, Cohen BJ, Wahren B 1991. Evaluation of a synthetic peptide enzyme linked immunosorbent assay for immunoglobulin M to human parvovirus B19. J Clin Microbiol 29: 1376-1381.
15. Gray JJ, Cohen BJ, Desselberger U 1993. Detection of human parvovirus B19 specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity. J Virol Meth 44: 11-24.
16. Hicks KE, Cubel RCN, Cohen BJ, Clewley JP 1996. Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the structural and nonstructural proteins. Arch Virol 141: 1319-1327.
17. Jensen IP, Vestergaard BF 1997. Assessment of a commercial human parvovirus B19 IgM assay. Clin Diag Virol 7: 133-137.
18. Kajigaya S, Fugii H, Field A, Anderson S, Rosenfeld S, Andersen LJ, Shimada T, Young NS 1991. Self-assembled B19 parvovirus capsids produced in a baculovirus system are antigenically and immunogenecally similar to native virions. Proc'Natl Acad Sci USA 88: 4646-4650.
19. Kerr S, O'Keeffe G, Kilty C, Doyle S 1999. Undenatured parvovirus B19 antigens are essencial for the accurate detection of parvovirus B19 IgG. J Med Virol 57: 179-185.
20. Kurtz JB, Anderson MJ 1985. Cross-reactions in rubella and parvovirus specific IgM tests. Lancet 2: 1356.
21. Morinet F, Courouce AM, Galibert F, Perol Y 1991. The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test. J Virol Meth 32: 21-30
22. Mortimer PP 1996. Antibody tests: progress and pitfalls. Clin Diag Virol 5: 131-136.
23. Nascimento JP, Mistchenko A, Cohen BJ 1998. Laboratory diagnosis of acute human parvovirus B19 infection by specific IgM detection. Rev Inst Med Trop São Paulo 40: 265-266.
24. Oliveira SA, Brandão AB, Fernandes DG, Bettini LR, Carvalho AB, Pereira ACM, Azevedo KM, Nascimento JP 1996. Human parvovirus B19: clinical and epidemiological study of 24 cases. Rev Inst Med Trop São Paulo 38: 323-327.
25. Pinheiro MG, Paula WNS, Aguiar FS, Pereira RFA, Nascimento JP 1997. Detecção de anticorpos anti-B19 pela técnica de western blotting. Anais do XXXIII Congresso da Sociedade Brasileira de Medicina Tropical, Belo Horizonte, p. 140-141.
26. Rosenfeld SR, Yoshimoto K, Kajigaya S, Anderson S, Young NS, Field A, Warrener P, Bansal G, Collet MS 1992. The unique region of the minor capsid protein of human parvovirus B19 is exposed on the viral surface. J Clin Invest 89: 2023-2029.
27. Schwarz TF, Modrow S, Hottenträger B, Höflacher B, Jager G, Schartt W, Sumazaki R, Wolf H, Middeldorp J, Roggendorf M, Deinhardt F 1991. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies. J Clin Microbiol 29: 431-435.
28. Saikawa T, Anderson S, Momoeda M, Kajigaya S, Young NS 1993. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 67: 3004-3009.
29. Sloots T, Devine PL 1996. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19. Eur J Clin Microbiol Infect Dis 15: 758-761.
30. Söderlund M, Brown CS, Cohen BJ, Hedman K 1995a. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 171: 710-713.
31. Söderlung M, Brown KE, Meurman O, Hedman K 1992. Prokaryoticexpression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol 30: 305-311.
32. Söderlund M, Brown CS, Spaan WJM, Hedman L, Hedman K 1995b. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 172: 1431-1436.
33. Thomas HIJ, Barrett E, Hesketh LM, Wynne A, Morgan-Capner P 1999. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol 14: 107-118.
34. Weissbrich B 1998. The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis. J Med Virol 54: 145-153.
35. Young NS 1996. Parvoviruses. In BN Fields, DM Knipe, PM Howley (eds), Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, p. 2199-2220.